on 09 Nov 2021
Last Applicant/ Owned by
1330 O'Brien Drive
Menlo Park
CA
94025
Serial Number
90080421 filed on 29th Jul 2020
Registration Number
6556422 registered on 09th Nov 2021
Correspondent Address
Laura C. Miller
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"LIQUID BIOPSY"
Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment "LIQUID BIOPSY"Read More
Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development
03rd Aug 2020
03rd Aug 2020
Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment
03rd Aug 2020
03rd Aug 2020
No 90080421
No Service Mark
No 1204171
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 09th Nov 2021 | REGISTERED-PRINCIPAL REGISTER |
| 05th Oct 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 04th Oct 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 21st Sep 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 21st Sep 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 20th Sep 2021 | ASSIGNED TO LIE |
| 14th Sep 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 08th Sep 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 08th Sep 2021 | NON-FINAL ACTION E-MAILED |
| 08th Sep 2021 | SU - NON-FINAL ACTION - WRITTEN |
